tiprankstipranks

Chris Ntoumenopoulos Insider Profile

4 Followers
Chris Ntoumenopoulos, Director at ResApp Health Limited, holds 85.26M shares in TrivarX Limited (Ticker: MDBIF), holds 3.61M shares in ResApp Health Limited (Ticker: AU:RAP), holds 1.04M shares in Race Oncology Ltd. (Ticker: AU:RAC).
tipranks
Chris  Ntoumenopoulos

Chris Ntoumenopoulos
ResApp Health Limited (RAP)
Director

Ranked #166 out of 99,024 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+279.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
52.42%
47.58%
A breakdown of Chris Ntoumenopoulos's holdings

Insider Roles

TrivarX Limited
(MDBIF)
Director
Race Oncology Ltd.
(RAC)
Senior Officer
Roles that Chris Ntoumenopoulos holds in companies

Most Profitable Insider Trade

Stock:
ResApp Health Limited
(RAP)
Rating:Informative Buy
Date:Jul 07, 2015 - Jul 07, 2016
Return:+800.00%
The most profitable trade made by Chris Ntoumenopoulos

Chris Ntoumenopoulos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RAP
ResApp Health Limited
Mar 16, 2021
Informative Buy
35.50K
AU$739.92K
Race Oncology Ltd.
Oct 14, 2019
Senior Officer
Informative Buy
25.00K
AU$1.55M
TrivarX Limited
Oct 16, 2023
Director
Uninformative Buy
27.88K
$1.71M
List of latest transactions for each holding click on a transaction to see Chris Ntoumenopoulos's performance on stock

Chris Ntoumenopoulos insider profile FAQ

What is the percentage of profitable transactions made by Chris Ntoumenopoulos?
The percentage of profitable transactions made by Chris Ntoumenopoulos is 80%.
    What is the average return per transaction made by Chris Ntoumenopoulos?
    The average return per transaction made by Chris Ntoumenopoulos is 279.50%.
      What stocks does Chris Ntoumenopoulos hold?
      Chris Ntoumenopoulos holds: AU:RAP, AU:RAC, MDBIF stocks.
        What was Chris Ntoumenopoulos’s latest transaction?
        Chris Ntoumenopoulos latest transaction was an Uninformative Buy of $27.88K.
          What was Chris Ntoumenopoulos's most profitable transaction?
          Chris Ntoumenopoulos’s most profitable transaction was an Informative Buy of AU:RAP stock on July 7, 2015. The return on the trade was 800.00%.
            What is Chris Ntoumenopoulos's role in ResApp Health Limited?
            Chris Ntoumenopoulos's role in ResApp Health Limited is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.